Cargando…
Nanosponges: An overlooked promising strategy to combat SARS-CoV-2
Among explored nanomaterials, nanosponge-based systems have exhibited inhibitory effects for the biological neutralization of, and antiviral delivery against, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). More studies could pave the path for clarification of their biological neutrali...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330373/ https://www.ncbi.nlm.nih.gov/pubmed/35908684 http://dx.doi.org/10.1016/j.drudis.2022.07.015 |
_version_ | 1784758144977600512 |
---|---|
author | Mostafavi, Ebrahim Iravani, Siavash Varma, Rajender S. |
author_facet | Mostafavi, Ebrahim Iravani, Siavash Varma, Rajender S. |
author_sort | Mostafavi, Ebrahim |
collection | PubMed |
description | Among explored nanomaterials, nanosponge-based systems have exhibited inhibitory effects for the biological neutralization of, and antiviral delivery against, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). More studies could pave the path for clarification of their biological neutralization mechanisms as well as the assessment of their long-term biocompatibility and biosafety issues before clinical translational studies. In this review, we discuss recent advances pertaining to antiviral delivery and inhibitory effects of nanosponges against SARS-CoV-2, focusing on important challenges and opportunities. Finally, as promising approaches for recapitulating the complex structure of different organs/tissues of the body, we discuss the use of 3D in vitro models to investigate the mechanism of SARS-CoV-2 infection and to find therapeutic targets to better manage and eradicate coronavirus 2019 (COVID-19). |
format | Online Article Text |
id | pubmed-9330373 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93303732022-07-28 Nanosponges: An overlooked promising strategy to combat SARS-CoV-2 Mostafavi, Ebrahim Iravani, Siavash Varma, Rajender S. Drug Discov Today Post-Screen (Grey) Among explored nanomaterials, nanosponge-based systems have exhibited inhibitory effects for the biological neutralization of, and antiviral delivery against, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). More studies could pave the path for clarification of their biological neutralization mechanisms as well as the assessment of their long-term biocompatibility and biosafety issues before clinical translational studies. In this review, we discuss recent advances pertaining to antiviral delivery and inhibitory effects of nanosponges against SARS-CoV-2, focusing on important challenges and opportunities. Finally, as promising approaches for recapitulating the complex structure of different organs/tissues of the body, we discuss the use of 3D in vitro models to investigate the mechanism of SARS-CoV-2 infection and to find therapeutic targets to better manage and eradicate coronavirus 2019 (COVID-19). Elsevier Ltd. 2022-10 2022-07-28 /pmc/articles/PMC9330373/ /pubmed/35908684 http://dx.doi.org/10.1016/j.drudis.2022.07.015 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Post-Screen (Grey) Mostafavi, Ebrahim Iravani, Siavash Varma, Rajender S. Nanosponges: An overlooked promising strategy to combat SARS-CoV-2 |
title | Nanosponges: An overlooked promising strategy to combat SARS-CoV-2 |
title_full | Nanosponges: An overlooked promising strategy to combat SARS-CoV-2 |
title_fullStr | Nanosponges: An overlooked promising strategy to combat SARS-CoV-2 |
title_full_unstemmed | Nanosponges: An overlooked promising strategy to combat SARS-CoV-2 |
title_short | Nanosponges: An overlooked promising strategy to combat SARS-CoV-2 |
title_sort | nanosponges: an overlooked promising strategy to combat sars-cov-2 |
topic | Post-Screen (Grey) |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330373/ https://www.ncbi.nlm.nih.gov/pubmed/35908684 http://dx.doi.org/10.1016/j.drudis.2022.07.015 |
work_keys_str_mv | AT mostafaviebrahim nanospongesanoverlookedpromisingstrategytocombatsarscov2 AT iravanisiavash nanospongesanoverlookedpromisingstrategytocombatsarscov2 AT varmarajenders nanospongesanoverlookedpromisingstrategytocombatsarscov2 |